Onderwerpen
Blogs
Reumatologie nieuws
- BiTE therapy for rheumatic diseases
- Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update by Hellmich et al
- Cardiac valve immune profiling in non-radiographic axial spondyloarthritis
- Eng Meng Tan
- Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus
- CPPD disease presenting with acute arthritis of the first metatarsophalangeal joint
- Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update by Fanouriakis et al
- 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
- Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
- Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
- Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology
- Inflammatory tissue priming: novel insights and therapeutic opportunities for inflammatory rheumatic diseases
- Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout
- Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update by Fanouriakis et al
- Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
19-08-2024
